Selvita, S.A., a leading clinical stage drug discovery company committed to developing innovative medicines for treatment of patients with cancer, announced the appointment of Setareh Shamsili, M.D., Ph.D., to the role of Chief Medical Officer.
July 25, 2019
· 3 min read